-
GSK invests heavily to expand operations and boost Sri Lanka’s investment profile
-
Will make significant positive impact on local pharmaceutical industry
  Glaxo SmithKline (GSK) celebrated the opening of their new pharmaceutical tablets manufacturing facility at a ceremony which was officiated by Hon. Basil Rajapakse, Minister of Economic Development and Hon Maithripala Sirisena, Minister of Health. The facility which was constructed and equipped at a cost of LKR 217 million, is for the production of Panadol along with other GSK pharma tablets and is one of Sri Lanka’s single largest investments in the pharmaceutical industry.
Designed to comply with GSK’s stringent global quality control and standards, the manufacturing facility is equipped with a state of the art laboratory operated by a cadre of trained staff. The quality of Panadol tablets produced at this facility will be on par with Panadol produced in countries like Australia and the UK.
 “This is a landmark project for us” said T.S Dayanand, Managing Director of GSK Sri Lanka “While it re-iterates GSK’s commitment towards strengthening the company’s long-standing foot print in this Country, we are delighted to play a key role in making a positive impact on local pharmaceutical industry, in keeping with the vision of HE President Mahinda Rajapakse”.
Elaborating further, he said “GSK employs over 500 people and conducts business with over 70 distributors and 150 suppliers, thereby touching many people’s lives. We will continue to live up to our vision of improving the quality of human life by enabling people to do more, feel better and live longer”.
About GlaxoSmithKline (GSK) -
GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical and healthcare company, operating in 117 Countries.
GSK has been in Sri Lanka for over 60 years serving Sri Lankan consumers with its trusted brands like Panadol (brand of paracetemol), Horlicks, Viva, Haliborange and more recently Eno, Iodex, Sensodyne and many pharmaceutical products and vaccines
Pix - Jayasiri Wickramasinghe |
